S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
NASDAQ:GOVX

GeoVax Labs News Headlines

$4.01
+0.12 (+3.08 %)
(As of 10/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.80
$4.06
50-Day Range
$3.76
$6.09
52-Week Range
$2.56
$8.71
Volume200,817 shs
Average Volume1.73 million shs
Market Capitalization$25.38 million
P/E RatioN/A
Dividend YieldN/A
Beta1.84

Media Mentions By Week

GeoVax Labs Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GOVX
News Sentiment

-0.53

0.35

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GOVX Articles
This Week

4

1

GOVX Articles
Average Week

Get GeoVax Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for GOVX and its competitors with MarketBeat's FREE daily newsletter.

GeoVax Labs (NASDAQ GOVX) News Headlines Today

SourceHeadline
finance.yahoo.com logoGeoVax Chief Scientific Officer to Participate in World Vaccine Congress Europe
finance.yahoo.com - October 18 at 10:31 AM
MarketBeat logoGeoVax Labs, Inc. (NASDAQ:GOVX) Sees Large Increase in Short Interest
americanbankingnews.com - October 15 at 12:41 PM
finance.yahoo.com logoGeoVax Receives Notice of Allowance for Ebola Vaccine Patent
finance.yahoo.com - October 14 at 10:19 AM
MarketBeat logoGeoVax Labs, Inc. (NASDAQ:GOVX) Short Interest Update
americanbankingnews.com - October 2 at 10:20 AM
finance.yahoo.com logoCompany News for Sep 30, 2021
finance.yahoo.com - September 30 at 1:20 PM
baystreet.ca logoGeoVax Vaults on Purchase
baystreet.ca - September 29 at 12:09 PM
finance.yahoo.com logo16 Stocks Moving in Wednesday's Pre-Market Session
finance.yahoo.com - September 29 at 12:09 PM
finance.yahoo.com logoGeoVax Stock Is Trading Higher On Gedeptin In-Licensing Pact For Solid Tumors
finance.yahoo.com - September 29 at 12:09 PM
finance.yahoo.com logoThe Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
finance.yahoo.com - September 29 at 12:09 PM
nasdaq.com logoGeoVax Labs Gets Exclusive Rights To Gedeptin
nasdaq.com - September 29 at 2:58 AM
finance.yahoo.com logoGeoVax Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program
finance.yahoo.com - September 29 at 2:58 AM
finance.yahoo.com logoGeoVax to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
finance.yahoo.com - September 7 at 9:07 AM
benzinga.com logoThinking about buying stock in Geovax Labs, Marker Therapeutics, Agile Therapeutics, FibroGen, or Pixelworks?
benzinga.com - August 21 at 10:56 AM
finance.yahoo.com logoMid-Afternoon Market Update: Crude Oil Down Over 2%; GeoVax Labs Shares Spike Higher
finance.yahoo.com - August 20 at 7:51 PM
finance.yahoo.com logoGeoVax Labs Stock Leaps on COVID-19 Vaccine Progress
finance.yahoo.com - August 20 at 5:00 PM
finance.yahoo.com logoWhy Is GeoVax Stock Shining Today?
finance.yahoo.com - August 20 at 2:51 PM
finance.yahoo.com logoWhy Geovax Labs Shares Are Soaring Today
finance.yahoo.com - August 20 at 2:51 PM
finance.yahoo.com logoGeoVax Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly
finance.yahoo.com - August 19 at 5:21 PM
finance.yahoo.com logoWe're Not Very Worried About GeoVax Labs' (NASDAQ:GOVX) Cash Burn Rate
finance.yahoo.com - August 17 at 9:07 AM
nasdaq.com logoGeoVax Labs (NASDAQ:GOVX) Is In A Good Position To Deliver On Growth Plans
nasdaq.com - August 15 at 3:42 PM
seekingalpha.com logoGeoVax Labs, Inc. (GOVX) CEO David Dodd on Q2 2021 Results - Earnings Call Transcript
seekingalpha.com - August 13 at 6:01 AM
finance.yahoo.com logoGeoVax to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021
finance.yahoo.com - August 12 at 2:59 PM
finance.yahoo.com logoGeoVax Reports 2021 Second Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - August 11 at 5:39 PM
finance.yahoo.com logoGeoVax to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update
finance.yahoo.com - August 4 at 10:08 AM
finance.yahoo.com logoGeoVax Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting
finance.yahoo.com - July 22 at 12:22 PM
benzinga.com logoGeoVax Highlights Yesterday Report Co Issued Hepatitis B Vaccine Patent
benzinga.com - July 7 at 10:03 AM
finance.yahoo.com logoGeoVax Announces Issuance of Hepatitis B Vaccine Patent
finance.yahoo.com - July 7 at 9:27 AM
finance.yahoo.com logoGeoVax to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium
finance.yahoo.com - June 10 at 12:26 PM
finance.yahoo.com logoGeoVax to Present at 2021 BIO Digital
finance.yahoo.com - June 7 at 9:30 AM
msn.com logoSmall-Cap Biotech Execs On Latest Advancements, Post-Pandemic Return To Fundamentals
msn.com - May 14 at 3:34 AM
finance.yahoo.com logoGeoVax Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit
finance.yahoo.com - May 11 at 1:33 PM
finance.yahoo.com logoGeoVax Reports 2021 First Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - May 6 at 4:36 PM
finance.yahoo.com logoGeoVax to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021
finance.yahoo.com - May 6 at 11:36 AM
finance.yahoo.com logoGeoVax to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update
finance.yahoo.com - April 26 at 9:58 AM
nasdaq.com logoStock Alert: GeoVax Labs Rises 25%
nasdaq.com - April 9 at 1:07 PM
finance.yahoo.com logoGeoVax Vaccine Innovation Is Poised To Save Lives Globally
finance.yahoo.com - April 8 at 2:39 PM
finance.yahoo.com logoGeoVax Receives Notice of Allowance for Hepatitis B Vaccine Patent
finance.yahoo.com - April 1 at 9:30 AM
finance.yahoo.com logoGeoVax to Participate in Benzinga Biotech Small Cap Conference
finance.yahoo.com - March 17 at 9:56 AM
finance.yahoo.com logoGeoVax to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference
finance.yahoo.com - March 10 at 9:40 AM
finance.yahoo.com logoGeoVax Expands and Strengthens Intellectual Property Portfolio
finance.yahoo.com - March 4 at 12:42 PM
finance.yahoo.com logoGeoVax to Present at the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 3 at 9:41 AM
finance.yahoo.com logoRegistration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring GeoVax’s CEO & CFO On March 3, 2021
finance.yahoo.com - March 1 at 9:18 AM
finance.yahoo.com logoIntroducing GeoVax Labs (NASDAQ:GOVX), The Stock That Zoomed 111% In The Last Year
finance.yahoo.com - February 18 at 12:22 PM
finance.yahoo.com logoGeoVax Announces Closing of $10.3 Million Bought Deal Offering
finance.yahoo.com - February 11 at 6:20 PM
finance.yahoo.com logoGeoVax Announces Pricing of $9.0 Million Bought Deal Offering
finance.yahoo.com - February 9 at 1:12 AM
nasdaq.com logoStock Alert: GeoVax Labs Nearly Doubles After Receiving Grant To Develop COVID-19 Vaccine
nasdaq.com - January 11 at 1:52 PM
finance.yahoo.com logoGeoVax Awarded NIH Grant to Advance COVID-19 Vaccine Development
finance.yahoo.com - January 11 at 1:52 PM
finance.yahoo.com logoGeoVax to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference
finance.yahoo.com - January 5 at 1:02 PM
markets.businessinsider.com logoNews for GeoVax Labs Inc Registered Shs
markets.businessinsider.com - December 14 at 6:11 AM
nasdaq.com logoGeoVax Labs Signs License Deal With NIH To Advance Vaccines Development
nasdaq.com - November 30 at 4:54 PM
Get GeoVax Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for GOVX and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 10/18/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.